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httpcense.Abstract Purpose: To evaluate the role of transperineal ultrasound (TPS) in the detection of mor-
phological and vascular manifestations of placenta previa (PP)/accreta and to compare it with
transabdominal sonography (TAS) and transvaginal sonography (TVS), with the clinical outcomes
as the reference standards.
Materials and methods: TPS, TVS, and TAS were carried on 134 patients after 28 weeks’ gestation
presented with antepartum hemorrhage. The ﬁnal diagnosis was obtained from the obstetrician at
time of delivery and from histopathological reports.
Results: One hundred and three patients had PP, the sensitivity, speciﬁcity, and accuracy in diag-
nosing PP were 97.1%, 75% and 94% for TPS, 94.2%, 75% and 91.5% for TAS, and 98.1%,
93.8% and 97.4% for TVS respectively. PP accreta was present in 39 patients. The sensitivity, spec-
iﬁcity, and accuracy in diagnosing PP accreta were 89.7%, 100% and 96% for TPS, 87%, 95% and
92.2% for TAS, and 94.9%, 100% and 98% for TVS respectively.
Conclusion: TPS is a valuable approach for evaluating patients with high risk of PP & PP accreta, it
is a safe, rapid, & accurate technique with little patient discomfort.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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PP is the most common diagnosable cause of antepartum hem-
orrhage, its incidence ranges from 2% to 6.3% depending
upon maternal age. Although previous curettage and abortion
are risk factors, patients with no previous surgery still have the
risk of PP (1–3).
Placenta accreta occurs when the chorionic villi abnormally
invade the myometrium. Based on histopathology it is divided
into three grades: placenta accreta (the chorionic villi are in
contact with the myometrium), placenta increta (the chorionic
villi invade the myometrium), and placenta percreta where theProduction and hosting by Elsevier B.V.
.08.004
Fig. 1 Normal anatomy by transperineal approach, the cervix is
horizontally oriented, UB: urinary bladder, CX: cervix. No
placental tissue interposed between the presenting part (head)
and the cervix (cx).
638 G.K. Gouhar et al.chorionic villi penetrate the uterine serosa. With increasing
rate of cesarean delivery, the incidence of both placenta previa
and placenta accreta (a collective term for accreta, increta and
percreta) is steadily increasing in frequency. The incidence of
placenta accreta has increased from approximately 1/30,000Fig. 2 Sonograms of placenta previa minor posterior. Transabdo
urinary bladder, CX: cervix, Pl: placenta; showing the lower margin o
the internal os. In TPS the cervix is horizontally oriented and the pladeliveries to 1/533 deliveries. The risk of placenta accreta in
patients with placenta previa is nearly 10% (4–7).
Placenta accreta unexpectedly encountered can lead to
catastrophic blood loss. It has become the leading cause of
emergency hysterectomy. Accurate preoperative diagnosis of
placenta accreta plays a crucial role in the management of
these complications. Antenatal sonography is used to help
the diagnosis and direct clinical management leading probably
to favorable outcomes. The antenatal detection rate of pla-
centa accreta on ultrasound ranges from 33% to 100% (8–13).
In patients with PP digital vaginal examination is contrain-
dicated because of the risk of provoking life-threatening
hemorrhage. In the anterior wall placenta transabdominal
ultrasound with a mildly ﬁlled maternal bladder might be a
suitable approach to identify the lower uterine segment. How-
ever, in the posterior wall placenta transvaginal ultrasound is
preferred (14–16).
Studies have demonstrated that while transvaginal sonogra-
phy is almost accurate in diagnosis and localization of PP, trans-
abdominal sonography is associated with incorrect diagnosis in
about 25% of the cases. Factors affecting the accuracy of TAS
are poor visualization of the posterior placenta, the fetal head
that can interfere with the visualization of the lower segment,
obesity and improper ﬁlling of the maternal bladder (17).
Because of safety concerns that prohibit vaginal manipula-
tion in patients with placenta previa transvaginal sonographyminal (a), transperineal (b) and transvaginal ultrasound (c),UB:
f the placenta (pl) reaching the cervix (cx) without encroaching on
centa is vertically oriented.
Fig. 3 Sonograms of placenta previa centralis with focal accreta. Transabdominal (a), transperineal (b) and transvaginal ultrasound (c),
CX: cervix, Pl: placenta; showing placental lacuna (*) with increased cervical vasculature (white arrow), and subplacental vasculature with
focal loss of subplacental sonolucent line (black arrow).
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an alternative imaging modality allowing cervical visualization
during the third trimester of pregnancy in most patients in
whom transabdominal sonography of this area is unsuccessful.
It provides a more convenient means of imaging the cervix and
lower uterus without requiring vaginal penetration, or external
fetal manipulation (18–20).
The goal of this study was to evaluate the role of transperi-
neal ultrasound (TPS) in the detection of morphological and
vascular manifestations of placenta previa/accreta and to com-
pare it with transabdominal sonography (TAS) and transvag-
inal sonography (TVS), with the clinical outcomes as the
reference standard.
2. Patients and methods
This prospective study was conducted at Zagazig university
hospitals, between March 2010 and April 2012. A total of
134 patients, pregnant after 28 weeks’ gestation presented with
antepartum hemorrhage and preliminary ultrasound examina-
tions suggestive of placenta previa (PP), were included. Institu-
tional review board approval and informed consent were taken
for all patients. Fifteen patients were missed during follow up
and/or labor, so they have been excluded from the analysis.
The remaining 119 patients were subjected to complete history
taking, full general and abdominal examination. TAS, TVSand TPS were done for the patients using Voluson 730 Pro
V machine (GE Healthcare, Austria) with a 3.5 MHz sector
transducer for TAS and TPS, and 7.5 MHz transvaginal trans-
ducer for TVS.
2.1. Transabdominal scanning
The examination was performed while the mother in the supine
position with her urinary bladder partially ﬁlled so as not to
distort the conﬁguration of the cervix or lower uterine seg-
ment. The gestational age was determined by measurement
of the biparietal diameter (BPD) and femur length (FL). Sono-
graphic evaluation of placenta previa requires visualization of
both the cervix and the lower edge of the placenta.
2.2. Transvaginal scanning
The patient was examined in the supine position with empty
urinary bladder. The transducer was inserted cautiously into
the vagina, up to a short distance from the cervix under contin-
uous observation of the image. No contact was made with the
cervix. A sagital scan of the whole length of the cervix and low-
er part of the uterus was obtained ﬁrst in each patient. If the
lower placental edge was not visualized in this plane, the trans-
ducer was then rotated 90 in each direction to visualize any
presence of placental tissue in the four quadrants of the lower
Fig. 4 Sonograms of placenta previa centralis accreta. Transabdominal (a), transperineal (b,c) and transvaginal ultrasound (d), showing
placental lacuna (*), loss of subplacental sonolucent line (black arrow), blood vessels are seen crossing the placenta into the myometrium
(white arrow).
640 G.K. Gouhar et al.uterine cavity. During rotation, adjustment of the transducer
was necessary to keep the internal cervical os continuously
visualized.
2.3. Transperineal scanning
Ultrasound gel was placed on the head of the same abdominal
transducer. A protective covering was applied to the trans-
ducer head, secured with a rubber band and an ultrasound
gel was applied to the other surface of the protective covering.
The examination was carried out while the patient lied supine
with her urinary bladder empty, and the thighs abducted sufﬁ-
ciently to allow placement and lateral angulation of the trans-
ducer. The transducer was placed directly over the perineum in
a sagittal orientation between the labia majora, usually directly
over the labia minora, but occasionally between them. The
center of the transducer was located posterior to the urethra
and anterior to the vagina. When the cervix and lower uterine
segment were visualized, the transducer was slowly angled
medially and laterally to image the entire internal surface of
the cervix.
For all US examinations the placenta was localized and
considered praevia if placental tissue was overlying any part
of the cervix. Criteria for diagnosis of PP were: 1) complete
previa––covers the internal os; 2) partial previa––partially
covering; or marginal––placental edge going to the internal
os.PP was excluded if at least one of the following was present:
1) The lower edge of the placenta seen separate from the cervix;
2) Amniotic ﬂuid between the presenting part and the cervix
without interposed placental tissue; 3) The presenting part
immediately overlying the cervix without intervening placental
tissue.
TAS was considered inadequate to exclude PP if the infe-
rior edge of the placenta could not be imaged or the cervix
could not be visualized.
For diagnosis of placenta accreta Gray-scale B-mode
sonography was ﬁrst used to screen the placental tissue in a
systematic fashion. Careful attention was paid to homogeneity
and echogenicity patterns of the placenta. Doppler was not
performed if on gray-scale imaging there was clear demarca-
tion of the placenta from the uterine wall.
The US ﬁndings for accreta based on Wong et al. (21)
have been described as: 1) Loss of the subplacental sonolu-
cent space at the site of accreta, 2) Thinning of the myome-
trium <1 mm, 3) With placenta percreta, there will be focal
disruption of the uterine serosa, extension of tissue outside
the uterus, and loss of the bladder wall echogenic mucosal
reﬂector.
Further assessment of the placenta was performed using
superimposed color and spectral Doppler ﬂow.
The color Doppler criteria suggestive of placenta previa
accreta that we assessed according to Chou et al. (4) included
the following:
Fig. 5 Sonograms of placenta previa centralis with focal accreta. Transabdominal (a), transperineal (b,c) and transvaginal ultrasound
(d,e), UB: urinary bladder, Pl: placenta; showing subplacental sonolucent line(white arrow), with focal increased subplacental vasculature
and loss of subplacental sonolucent line (black arrow).
Role of transperineal sonography in diagnosis of placenta previa/accreta: A prospective study 6411. A diffuse lacunar ﬂow pattern exhibiting diffusely
dilated vascular channels scattered throughout the whole
placenta and the surrounding myometrial or cervical
tissues.
2. A focal lacunar ﬂow pattern showing irregular sonolucent
vascular lakes distributed focally within the intraparenchy-
mal placental area.
3. Interphase hypervascularity with abnormal blood vessels
linking the placenta to the bladder.
4. Markedly dilated peripheral subplacental vascular
channels.The intraoperative data were obtained from the obstetri-
cian at time of delivery and the histopathological data were ob-
tained from histopathological reports. The statistical software
package SPSS version 10.0 was used for data analysis. A prob-
ability value of <0.05 was taken as statistically signiﬁcant.
3. Results
One hundred nineteen patients were included in this study with
mean age of 27 ± 4.6 years, and mean gestational age of
Fig. 6 Sonograms of placenta previa increta. Transabdominal (a), transperineal (b,c) and transvaginal ultrasound (d), CX: cervix, Pl:
placenta; showing placental lacunae (*), loss of subplacental sonolucent zone (black arrow), with blood vessels at the uterus-urinary
bladder interface but not reaching the UB lumen (white arrow).
642 G.K. Gouhar et al.36.0 ± 5.5 weeks. According to the delivery outcome 103 pa-
tients had placenta previa (41 patients had complete placenta
previa, and 62 patients had partial placenta previa), while the
remaining 16 patients had no placenta previa. Illustrative cases
are presented in (ﬁg. 1–7). TPS diagnosed PP in 104 patients,
and was excluded in 15 patients. There were three false negative
cases, and four false positive cases on TPS. TAS and TVS were
suggestive of PP in 101 and 102 patients respectively, and ex-
cluded PP in 18 and 17patients respectively (Table 1)
There were 6 false negative cases, and 4 false positive cases
on TAS, while on TVS there were two false negative cases, and
one false positive case.
The sensitivity, speciﬁcity, and accuracy in diagnosing PP
were 97.1%, 75% and 94% for TPS, 94.2%, 75% and
91.5% for TAS, and 98.1%, 93.8% and 97.4% for TVS,
respectively (Table 2).
Among 103 patients positive for PP 39 patients were proved
to have PP accreta based on delivery outcome. The clinical
data of these patients are shown in (Table 3). Twelve of the
39 patients had history of cesarean sections, nine had history
of dilatation and curettage, and eighteen patients had history
of both operations.
PP accreta was correctly diagnosed in 35/39 patients by
TPS and in 34 and 37 patients by TAS and TVS respectively
(Table 4).
On grey scale TPS there was loss of the subplacental sono-
lucent space in all (35) cases with PP accreta, focal disruption
of the uterine serosa with loss of the bladder wall echogenic
mucosal reﬂector was seen in 17 patients with PP increta and
in 7 patients with PP percreta.On color Doppler TPS examination focal lacunar ﬂow pat-
tern within the intraparenchymal placental area was seen in 7
patients with PP accreta, 11 patients with PP increta and in 2
patients with PP percreta, diffuse lacunar ﬂow pattern scat-
tered throughout the whole placenta was seen in 4 patients
with PP accreta, 8 patients with PP increta and in 5 patients
with PP percreta, dilated peripheral subplacental vascular
channels was seen in 4 patients with PP accreta, 3 patients with
PP increta and in 4 patients with PP percreta, interphase
hypervascularity with abnormal blood vessels linking the
placenta to the bladder in 14 patients with PP increta and in
7 patients with PP percreta.
There were 4 cases of false negative PP accreta diagnosed
by TPS, 5 cases by TAS, and 2 cases by TVS.
The sensitivity, speciﬁcity, and accuracy in diagnosing PP
accreta were 89.7%, 100% and 96% for TPS, 87%, 95%
and 92.2% for TAS, and 94.9%, 100% and 98% for TVS
respectively (Table 5).4. Discussion
Accurate diagnosis of pp is essential to avoid major obstetric
complications. Ultrasound is the gold standard method of
diagnosis. Lower segment placenta carries difﬁcult diagnosis
as it is crowded into a smaller space with more attenuation
of sound waves (22).
Accuracy of placental localization has been studied exclu-
sively in many studies. Rani et al. compared TPS & TAS for
diagnosis of pp. There was six cases of false positive diagnosed
Fig. 7 Sonograms of placenta previa percreta. Transabdominal (a), transperineal (b) and transvaginal ultrasound (c), ub: urinary
bladder, CX: cervix, Pl: placenta; showing placental and cervical lacunae (*), and crossing blood vessels to urinary bladder mucosa
(arrow).
Table 2 Comparison between TAS, TVS, and TPS in
diagnosis of PP.
TAS TVS TPS
Sensitivity (%) 94.2 98.1 97.1
Speciﬁcity (%) 75 93.8 75
Positive predictive value (%) 96 99 96.2
Negative predictive value (%) 66.7 88.2 80
Accuracy (%) 91.5 97.4 94
Kappa test 0.65 0.89 0.74
P value 0.0001 0.0001 0.0001
Table 1 Validity of TAS, TVS, and TPS in diagnosis of PP.
Type of placenta TAS TVS TPS Final diagnosis
Positive for PP
Complete 57 60 61 62
Partial 44 42 43 41
Negative for PP 18 17 15 16
Total 119 119 119 119
Role of transperineal sonography in diagnosis of placenta previa/accreta: A prospective study 643with TAS (69 out of 75), PPV 92% with TPS, one case of false
positive, no false negative (100% sensitivity, 83.33 speciﬁcity,
98.57 PPV & 100% NPV) (23)Adeyomoye et al. (24) compared TPS & TAS in the diagno-
sis of PP. The overall sensitivity, speciﬁcity, and accuracy of
TPS were (99.2%, 100% &99.3%) for TAS (95.1, 99.9%
&97.7%).
Mowaﬁ et al. (14) in their study showed TPS to be superior
to TAS in localization of placenta, with sensitivity, speciﬁcity,
PPV, NPV & accuracy, 98.5%, 97.5%, 94.8%, 99.1% and
97.75 respectively.
Hertzberg et al. (20), Dawson et al. (25), Patel 2000 (26)&
Xiao-qing et al. (27) studied the value of TPS in that combina-
tion of both approaches is superior to one of them alone in
diagnosing placental location.
In agreement with previous studies, in our study TPS suc-
cessfully diagnosed PP in 104 patients & excluded in 15 pa-
tients. There were three false negative cases & four false
positive cases. The sensitivity, speciﬁcity & accuracy in diag-
nosing PP were 97.1%, 75% & 94% for TPS and 94.2%,
75%, & 91.5 for TAS.
Although TAS is usually successful in visualization of the
cervix during the 2nd trimester of pregnancy, visualization be-
comes progressively more difﬁcult during the 3rd trimester. To
this end, techniques have been tried in the form of trying to ele-
vate the fetal presenting part from the pelvis but this is uncom-
fortable to the patient & mostly unsuccessful (28).
A potential difﬁculty with TPS is the presence of rectal gas
obscuring the region of the external os, but this did not consti-
Table 4 Validity of TAS, TVS, and TPS in diagnosis of PP
accreta.
Type of Placenta TAS TVS TPS Final diagnosis
PP accreta 9 11 14 12
PP increta 19 19 14 17
PP percreta 6 7 7 10
Total 34 37 35 39
Table 5 Comparison between TAS, TVS, and TPS in
diagnosis of PP accreta.
TAS TVS TPS
Sensitivity (%) 87 94.9 89.7
Speciﬁcity (%) 95 100 100
Positive predictive value (%) 92 100 100
Negative predictive value (%) 92.4 97 94.1
Accuracy (%) 92.2 98 96.1
Kappa test 0.83 0.95 0.91
P value >0.0001 >0.0001 >0.0001
Table 3 Clinical data of 39 patients with PP accreta.
Data Number
1-Previous surgery  Cesarean section (SC) 12 cases
 D&C 9 cases







 Antepartum hemorrhage 19 cases
 Elective 20 cases
644 G.K. Gouhar et al.tute any problem with patient with PP because looking for pla-
cental tissue overlying the cervix necessitates visualization of
the internal surface of the cervix. (19).
Another approach is to use TVS for diagnosing placental
location. In our study TVS is used in comparison to TAS &
TPS in diagnosing PP. TVS showed 98.1% sensitivity, 93.8%
speciﬁcity, 99% PPV & 88.2 NPV & 97.4% accuracy.
With the ﬁrst use of TVS in diagnosing PP by farine et al.
(29),TVS correctly identiﬁed placenta previa in 29 of 34 pa-
tients compared to only 16 to 34 identiﬁed trans-abdominally.
In 1992, Sherman & Colleagues (30) in their study of TVS
in diagnosing PP showed that TVS provided superior clarity of
diagnosis.
Ghourab in 2001 (31),studied 128 Patients with TVS. All of
them have either clinical suspicion or TAS diagnosis of PP.
TVS excluded the diagnosis of PP in 34 out of 138 patients
(24.6%), none of them had cesarean section due to bleeding.
They concluded that lower placental edge shape seen on TVS
may improve the predication of mode of delivery & the clinical
outcome.
Discussion of PP would not be completed without diagnosis
of abnormal placental adherence (Placenta accreta) which car-
ries major risks up to maternal death (17).
Guy & associates in 1990 (32) ﬁrst used TVS for prenatal
diagnosis of PP accreta in 16 patients with PP.In 2000, Chou & Co-workers (33) studied 80 patients with
persistent placental previa underwent TAS (B-mode and color
Doppler US), their study showed 82.4% sensitivity, 96.8%
speciﬁcity , PPV 87.5% & NPV 95.3%.
In our study, TAS showed sensitivity, speciﬁcity, PPV, NPV,
and accuracy of 87, 95%, 92%, 92.4%, and 92.2% respectively
in diagnosing PP accreta with gray scale & color Doppler.
Yang et al. (34), studied the role of TVS ﬁnding of intra-
placental lacunae in patients with placenta previa totalis with
previous C.S. in the prediction of placenta accreta. They con-
cluded that intraplacental lacunae can be useful in patients
with PP to predict abnormal placental adherence.
To our knowledge, no previous studies compared the
three approaches (TAS, TVS, and TPS) for the diagnosis
of PP & to predict abnormal placental adhesions. In our
study the sensitivity, speciﬁcity, PPV, NPV, and accuracy
were 94.9%, 100%, 100%, 97%, 98% & 89.7%, 100%,
100%, 94.1%, 96% for TVS and TPS, respectively for pre-
dicting PP accreta.
With advanced gestation visualization of the cervix &
lower edge of the placenta which are essential for diagnosing
placenta previa, becomes more difﬁcult by TAS. Both TPS
& TVS are valuable techniques to complement TAS for
the diagnosis of placenta previa & abnormal placental adhe-
sions. However, TPS showed to have advantages over TVS
because of less discomfort, no need for specialized equip-
ment, and avoidance of vaginal penetration especially in
cases where risk of infection is present e.g. PROM, or di-
lated external os.
In conclusion; being a safe, rapid, & accurate technique
with little patient discomfort; TPS is a valuable approach for
evaluating these high risk group of patients with PP & PP
accreta.
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